Immunoconjugates of anti-IL-20 antibodies and hybridoma cell...

Details Immunoconjugates of anti-IL-20 antibodies and hybridoma cell... Immunoconjugates of anti-IL-20 antibodies and hybridoma cell...

2008-07-01

2008-07-01

Belyavskyi, Michail (Department: 1644)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Animal cell, per se, expressing immunoglobulin, antibody, or...

C530S391700, C530S391300

Reexamination Certificate

active

07393684

ABSTRACT:
The present invention relates to blocking the activity of IL-20 polypeptide molecules. IL-20 is a cytokine that is involved in inflammatory processes and human disease. IL-20RA/IL-20RB is a common receptor for IL-20. The present invention includes anti-IL-20 antibodies and binding partners, as well as methods for antagonizing IL-20 using such antibodies and binding partners.

REFERENCES:
patent: 5723299 (1998-03-01), Bell et al.
patent: 5789192 (1998-08-01), Moore et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 5945511 (1999-08-01), Lok et al.
patent: 5985614 (1999-11-01), Rosen et al.
patent: 6020163 (2000-02-01), Conklin
patent: 6486301 (2002-11-01), Ebner et al.
patent: 6576743 (2003-06-01), Conklin et al.
patent: 6610286 (2003-08-01), Thompson et al.
patent: 2002/0042366 (2002-04-01), Thompson et al.
patent: 2004/0152878 (2004-08-01), Conklin et al.
patent: 2004/0181040 (2004-09-01), Conklin et al.
patent: 2006/0134756 (2006-06-01), Xu et al.
patent: WO94/13801 (1994-06-01), None
patent: WO99/03982 (1999-01-01), None
patent: WO99/07740 (1999-02-01), None
patent: WO99/07848 (1999-02-01), None
patent: WO99/27103 (1999-06-01), None
patent: WO99/37772 (1999-07-01), None
patent: WO99/46281 (1999-09-01), None
patent: WO99/46379 (1999-09-01), None
patent: WO99/61630 (1999-12-01), None
patent: WO00/12708 (2000-03-01), None
patent: WO00/39161 (2000-07-01), None
patent: WO00/42189 (2000-07-01), None
patent: WO00/73457 (2000-12-01), None
patent: WO00/78961 (2000-12-01), None
patent: WO01/12672 (2001-02-01), None
patent: WO01/46261 (2001-06-01), None
patent: WO02/12345 (2002-02-01), None
patent: WO02/058724 (2002-08-01), None
patent: WO02/070001 (2002-09-01), None
patent: WO02/072607 (2002-09-01), None
patent: WO03/039444 (2003-05-01), None
patent: WO03/051384 (2003-06-01), None
patent: WO2004/085475 (2004-10-01), None
Koumenis et al., Int J Pharm. Mar. 30, 2000;198(1):83-95.
Rich et al., Expert Opin Ther Targets. Apr. 2003;7(2):165-74.
Reff et al., Crit Rev Oncol Hematol. Oct. 2001;40(1):25-35.
Simon et al., J Biol Chem. May 5, 1993;268(13):9771-9.
Abbas et al., “Cellular and Molecular Immunology”,4th Ed., pp. 519-520, W.B. Saunders Company, 2000.
Albert et al., “Molecular Biology of the Cell,” 3rdEd., pp. 156-159, Garland Publishing, Inc., 1994.
Asadullah et al.,Arch Dermatol 138:1189-1196, 2002.
Asadullah et al.,Pharmacol Rev. 55(2):241-269, 2003.
Blumberg et al.,Cell 104:9-19, 2001.
Cameron et al., “Cytokines and Chemokines in Autoimmune Disease,” pp. 8-32, Eurekah.com and Klawer Academic/Plenum Publishers, 2003.
Conti et al.,Immunology Letters 88:171-174, 2003.
Cunningham et al.,Science 244:1081-1085, 1989.
Davis et al.,Cell 87:1161-1169, 1996.
De Groot-Kruseman et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-97, Abstract P-2-1, 2002.
Dumoutier et al.,Eur. Cytokin Netw 13(2):5-15, 2002.
Dumoutier et al.,J. Immunol. 167:3545-3549, 2001.
Dynan et al.,Nature 316:774-778, 1985.
Fickenscher et al.,TRENDS in Immunology 23(2):89-96, 2002.
George et al., “Macromolecular Sequencing & Synthesis,” pp. 127-149, Ch. 12, Alan R. Liss, Inc., 1988.
Gröne,Veterinary Immunol. And Immunopathal. 88:1-12, 2002.
Harlow et al., “Antibodies A Laboratory Manual,” p. 76, Ch. 5, Cold Springs Harbor Laboratory, 1988.
He et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-97, Abstract P-1-23, 2002.
Henikoff et al.,Proc. Nat. Acad. Sci. USA 89:10915-10919, 1992.
Hosoi et al.,The 75thAnnual Meeting, Department of Pharmacology, Kumamoto University, p. 89P, Abstract P-112, 2002.
Kotenko,Cytokine&Growth Factor Reviews 13:223-240, 2002.
Kotenko et al.,J. Biol. Chem. 276(4):2725-2732, 2001.
Kotenko et al.,Oncogone 19:2557-2565, 2000.
Kunz et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-97-S-98, Abstract P-2-3, 2002.
Last et al.,J. Investigative Dermatology 119(1):325, Abstract 707, 2002.
Liu et al.,Blood 100(11):189a-190a, Abstract #710, 2002.
Liu et al.,Journal of Immunology 152:1821-1829, 1994.
Liu et al.,Blood 102(9):3206-3209, 2003.
Lutfalla et al.,Genomics 16:366-373, 1993.
Lutfalla et al.,J. Mol. Evolution 41:338-344, 1995.
Lillehoj et al., “Antibody Techniques,” pp. 291-305, Ch. 13, Academic Press, Inc., 1994.
McKinnon et al.,Drug News and Perspectives 9(7):389-398, 1996.
Merck Manual 17thEd., pp. 920-925, 1979, Sep. 17, 2006.
Mohler et al.,FASB J. US Fed of American Soc. For Experimental Biology 6(4):A1123, 1992.
Musso et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-98, Abstract P-2-4, 2002.
Ozaki et al.,J. Biol. Chem. 277(33):29355-29358, 2002.
Parrish-Novak et al.,J. Biol. Chem.277(49):47517-47523, 2002.
Parrish-Novak et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-46, Abstract W-1-5, 2002.
Pirhonen et al.,J. Interferon&Cytokine Research 22(Suppl. 1): S-98, Abstract P-2-6, 2002.
Ramesh et. al.,Cancer Gene Therapy: S3, Abstract 008, 2002.
Rich et al.,Curr Biol. 11(13):R531-R534, 2001.
Rich,Expert Opin. Ther. Targets 7(2):165-174, 2003.
Rohovsky et al., “Growth Factors and Wound Healing” pp. 8-26, Ch. 2, Springer, 1997.
Roitt et al., “Immunology,” 4thEd., pp. 28.10-28.12, Mosby, 1996.
Rose-John,Acta Biochimica Polonica 50(3):603-611, 2003.
Salazar et al.,Eur. J. of Clin. Invest. 31(12):1070-1077, 2001.
Slavin,J. Immunol. Immunopharmacol 17(1):25-29, 1997.
Stolina et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-98-S-99, Abstract P-2-7, 2002.
Strengell et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-99, Abstract P-2-8, 2002.
Tachiiri et al.,Genes and Immunity 4:153-159, 2003.
Vandenbroeck et al.,J. Biol. Chem. 277(28):25668-25676, 2002.
Volk et al.,TRENDS in Immunology 22(8):414-417, 2001.
Walter,Immunologic Res. 26(1-3):303-308, 2002.
Whitters et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-99-S-100, Abstract P-2-11, 2002.
Witek et al.,J. Interferon&Cytokine Research 22(Suppl. 1):S-100, Abstract P-2-12, 2002.
Wolk et al.,J. Immunol. 168:5397-5402, 2002.
Wuyts et al.,Eur J. Biochem. 260:421-429, 1999.
Xie et al.,J. Biol. Chem. 275(40):31335-31339, 2000.
Xu et al.,Proc. Nat. Acad. Sci. USA. 98(17):9511-9516, 2001.
EST from Incyte Pharmaceuticals Inc., INC1429789, 1996.
EST from Incyte Pharmaceuticals Inc., INC1922140, 1996.
EST from Incyte Pharmaceuticals Inc., INC1923851, 1996.
EST from Incyte Pharmaceuticals Inc., INC2119350, 1996.
EST from Incyte Pharmaceuticals Inc., INC2270605, 1996.
EST from Incyte Pharmaceuticals Inc., INC2699058, 1997.
EST from Incyte Pharmaceuticals Inc., INC2701079, 1997.
EST from Incyte Pharmaceuticals Inc., INC2720417, 1997.
EST from Incyte Pharmaceuticals Inc., INC2763478, 1997.
EST from Incyte Pharmaceuticals Inc., INC3256488, 1997.
EST from Incyte Pharmaceuticals Inc., INC3257185, 1997.
EST from Incyte Pharmaceuticals Inc., INC3316826, 1997.
EST from Incyte Pharmaceuticals Inc., INC3376533, 1997.
EST from Incyte Pharmaceuticals Inc., INC357666, 1995.
EST from Incyte Pharmaceuticals Inc., INC4304592, 1998.
EST from Incyte Pharmaceuticals Inc., INC758088, 1996.
EST from Incyte Pharmaceuticals Inc., INC819592, 1996.
EST from Incyte Pharmaceuticals Inc., INC904360, 1996.
EST from TIGR Tentative Human Consensus, THC174656, 1997.
EST from TIGR Tentative Human Consensus, THC197949, 1997.
EST from TIGR Tentative Human Consensus, THC215509, 1997.
GenBank Accession No. AA018585, 1995.
GenBank Accession No. AA018749, 1995.
GenBank Accession No. AA035594, 1995.
GenBank Accession No. AA132964, 1995.
GenBank Accession No. AA134881, 1995.
GenBank Accession No. AA135185, 1995.
GenBank Accession No. AA135300, 1995.
GenBank Accession No. AA299011, 1995.
GenBank Accession No. AA412292, 1997.
GenBank Accession No. AA470014, 1997.
GenBank Accession No. AA494556, 1997.
GenBank Accession No. AA514541, 1997.
GenBank Accession No. AA516435, 1997.
GenBank Accession No. AA528216, 1997.
GenBank Accession No. AA583432, 1997.
GenBank Accession No. AA632915, 1997.
GenBank Accession No. H17201, 1995.
GenBank Accession No. H17978, 1995.
GenBank Accession No. N62509, 1995.
GenBan

Affiliated with

Also associated with

Rating

Immunoconjugates of anti-IL-20 antibodies and hybridoma cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoconjugates of anti-IL-20 antibodies and hybridoma cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoconjugates of anti-IL-20 antibodies and hybridoma cell... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2744352